Stock Research for PSTI

PSTI

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

PSTI Stock Chart & Research Data

The PSTI chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the PSTI chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


PSTI Due diligence Resources & Stock Charts

The PSTI stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View PSTI Detailed Price Forecast - CNN Money CNN View PSTI Detailed Summary - Google Finance
Yahoo View PSTI Detailed Summary - Yahoo! Finance Zacks View PSTI Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View PSTI Trends & Analysis - Trade-Ideas Barrons View PSTI Major Holders - Barrons
NASDAQ View PSTI Call Transcripts - NASDAQ Seeking View PSTI Breaking News & Analysis - Seeking Alpha
Spotlight View PSTI Annual Report - CompanySpotlight.com OTC Report View PSTI OTC Short Report - OTCShortReport.com
TradeKing View PSTI Fundamentals - TradeKing Charts View PSTI SEC Filings - Bar Chart
WSJ View Historical Prices for PSTI - The WSJ Morningstar View Performance/Total Return for PSTI - Morningstar
MarketWatch View the Analyst Estimates for PSTI - MarketWatch CNBC View the Earnings History for PSTI - CNBC
StockMarketWatch View the PSTI Earnings - StockMarketWatch MacroAxis View PSTI Buy or Sell Recommendations - MacroAxis
Bullish View the PSTI Bullish Patterns - American Bulls Short Pains View PSTI Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View PSTI Stock Mentions - StockTwits PennyStocks View PSTI Stock Mentions - PennyStockTweets
Twitter View PSTI Stock Mentions - Twitter Invest Hub View PSTI Investment Forum News - Investor Hub
Yahoo View PSTI Stock Mentions - Yahoo! Message Board Seeking Alpha View PSTI Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for PSTI - SECform4.com Insider Cow View Insider Transactions for PSTI - Insider Cow
CNBC View PSTI Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for PSTI - OTC Markets
Yahoo View Insider Transactions for PSTI - Yahoo! Finance NASDAQ View Institutional Holdings for PSTI - NASDAQ


Stock Charts

FinViz View PSTI Stock Insight & Charts - FinViz.com StockCharts View PSTI Investment Charts - StockCharts.com
BarChart View PSTI Stock Overview & Charts - BarChart Trading View View PSTI User Generated Charts - Trading View




Latest Financial News for PSTI


Pluristem Therapeutics Announces Completion of 2nd Cohort and DSMB Approval to Enroll Final Cohort in Phase I Hematological Study of PLX-R18
Posted on Tuesday March 12, 2019

Pluristem Therapeutics Inc. (PSTI) (PSTI.TA), a leading regenerative medicine company developing novel placenta-based cell therapy products, today announced that the Company has fully enrolled the second cohort of six patients in its ongoing Phase I clinical study evaluating PLX-R18 for the treatment of incomplete hematopoietic recovery following hematopoietic cell transplantation (HCT), and has received Data and Safety Monitoring Board (DSMB) approval to continue to the final cohort of the study. “We are highly encouraged by the findings from the first two cohorts in this study, and we are pleased to receive DSMB approval to continue with the study as planned, as we look to efficiently advance PLX-R18 through clinical development,” commented Zami Aberman, Chairman and Co-Chief Executive Officer of Pluristem.


Is Pluristem Therapeutics Inc.’s (NASDAQ:PSTI) Balance Sheet A Threat To Its Future?
Posted on Thursday March 07, 2019

Zero-debt allows substantial financial flexibility, especially for small-cap companies like Pluristem Therapeutics Inc. (NASDAQ:PSTI), as the company does not have to adhere to strict debt covenants. However, it also facesRead More...


Pluristem Enters into Collaboration with NASA to Study PLX Therapeutic Benefits in Space Missions
Posted on Wednesday February 20, 2019

Pluristem Therapeutics Inc. (PSTI) (PSTI.TA), a leading regenerative medicine company developing novel placenta-based cell therapy products, today announced a collaboration between the company and NASA’s Ames Research Center to evaluate the potential of Pluristem’s PLX cell therapies in preventing and treating medical conditions caused during space missions. Dr. Ruth Globus of NASA’s Ames Research Center, in California’s Silicon Valley, has been awarded a 2019 NASA Ames Research Innovation Award (ARIA) for the collaboration with Pluristem.


Pluristem Therapeutics Sees Hammer Chart Pattern: Time to Buy?
Posted on Thursday February 14, 2019

Pluristem Therapeutics Inc. (PSTI) has been struggling lately, but the selling pressure may be coming to an end soon.


Stock Market & Investing Books

Enter a stock symbol to view the stock details.